KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells

Molecular and Cellular Biology

Volumn 33, Issue 24, 2013, Pages 4919-4935

  Zhang, Baotong ^a,b   Zhang, Zhiqian ^a,b   Xia, Siyuan ^a   Xing, Changsheng ^a,b   Ci, Xinpei ^a   Li, Xin ^a   Zhao, Ranran ^a   Tian, Sha ^a   Ma, Gui ^a   Zhu, Zhengmao ^a   Fu, Liya ^a   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; F ACTIN; FIBRONECTIN; KRUPPEL LIKE FACTOR 5; MICRORNA 141; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; MICRORNA 429; PROTEIN ZO1; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; KLF5 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MICRORNA; MIRN200 MICRORNA, HUMAN; SMALL INTERFERING RNA; PROTEIN BINDING;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REPRESSOR GENE; RNA TRANSCRIPTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BINDING SITE; CARCINOGENESIS; CELL STRAIN HEPG2; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE; PROTEIN BINDING; HEPG2 CELL LINE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CARCINOGENESIS; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; PROMOTER REGIONS, GENETIC; PROSTATE; PROTEIN BINDING; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84893055415     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00787-13     Document Type: Article

References (88)

1. Shi H, Zhang Z, Wang X, Liu S, Teng CT. 1999. Isolation and characterization of a gene encoding human Kruppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter. Nucleic Acids Res. 27:4807-4815.
2. Sur I, Unden AB, Toftgard R. 2002. Human Kruppel-like factor5/KLF5: synergy with NF-kappaB/Rel factors and expression in human skin and hair follicles. Eur. J. Cell Biol. 81:323-334.
3. Wan H, Luo F, Wert SE, Zhang L, Xu Y, Ikegami M, Maeda Y, Bell SM, Whitsett JA. 2008. Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development 135:2563-2572.
4. Chen C, Bhalala HV, Vessella RL, Dong JT. 2003. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55:81-88.
5. Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C. 2009. Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene 28:3702-3713.
6. McConnell BB, Kim SS, Yu K, Ghaleb AM, Takeda N, Manabe I, Nusrat A, Nagai R, Yang VW. 2011. Kruppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology 141:1302-1313.
7. Bateman NW, Tan D, Pestell RG, Black JD, Black AR. 2004. Intestinal tumor progression is associated with altered function of KLF5. J. Biol. Chem. 279:12093-12101.
8. Dong JT, Chen C. 2009. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell. Mol. Life Sci. 66:2691-2706.
9. Kuo PL, Hsu YL, Huang MS, Chiang SL, Ko YC. 2011. Bronchial epithelium-derived IL-8 and RANTES increased bronchial smooth muscle cell migration and proliferation by Kruppel-like factor 5 in areca nutmediated airway remodeling. Toxicol. Sci. 121:177-190.
10. Yang Y, Tetreault MP, Yermolina YA, Goldstein BG, Katz JP. 2008. Kruppel-like factor 5 controls keratinocyte migration via the integrinlinked kinase. J. Biol. Chem. 283:18812-18820.
11. Yang Y, Nakagawa H, Tetreault MP, Billig J, Victor N, Goyal A, Sepulveda AR, Katz JP. 2011. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res. 71:6475-6484.
12. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelialmesenchymal transitions in development and disease. Cell 139:871-890.
13. Shimamura T, Imoto S, Shimada Y, Hosono Y, Niida A, Nagasaki M, Yamaguchi R, Takahashi T, Miyano S. 2011. A novel network profiling analysis reveals system changes in epithelial-mesenchymal transition. PLoS One 6:e20804. doi:10.1371/journal.pone.0020804.
14. Black AR, Black JD, Azizkhan-Clifford J. 2001. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188:143-160.
15. Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K. 2012. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition. Mol. Cell. Biol. 32:941-953.
16. Tiwari N, Meyer-Schaller N, Arnold P, Antoniadis H, Pachkov M, van Nimwegen E, Christofori G. 2013. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One 8:e57329. doi:10.1371/journal.pone.0057329.
17. Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu C, Xiao X, Wu K, Nie Y, Zhang H, Fan D. 2013. KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. J. Cancer Res. Clin. Oncol. 139:1033-1042.
18. Wang X, Lu H, Urvalek AM, Li T, Yu L, Lamar J, DiPersio CM, Feustel PJ, Zhao J. 2011. KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene 30:1901-1911.
19. Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, Katsaros D, Coukos G, Zhang L, Huang Q. 2009. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat. Cell Biol. 11:1297-1304.
20. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW. 2005. Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 15:92-96.
21. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26:101-106.
22. Guo P, Dong XY, Zhang X, Zhao KW, Sun X, Li Q, Dong JT. 2009. Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J. Biol. Chem. 284:6071-6078.
23. Xing C, Fu X, Sun X, Guo P, Li M, Dong JT. 2013. Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells. PLoS One 8:e65538. doi:10.1371/journal.pone.0065538.
24. Zeisberg M, Neilson EG. 2009. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119:1429-1437.
25. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119:1420-1428.
26. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, Palacios J, Portillo F, Cano A. 2009. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat. Protoc. 4:1591-1613.
27. Xu J, Lamouille S, Derynck R. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156-172.
28. Fuxe J, Vincent T, Garcia de Herreros A. 2010. Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 9:2363-2374.
29. Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, Moses HL. 2004. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res. 6:R215-R231.
30. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. 2005. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell. Biochem. 95:918-931.
31. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. 2009. Micro-RNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9:293-302.
32. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10:593-601.
33. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283:14910-14914.
34. Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the Ecadherin repressors ZEB1 and ZEB2. Genes Dev. 22:894-907.
35. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. 2011. p53 regulates epithelial-mesenchymal transition through micro-RNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208:875-883.
36. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. 2008. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28:6773-6784.
37. Zhang Z, Zhang B, Li W, Fu L, Fu L, Zhu Z, Dong JT. 2011. Epigenetic silencing of miR-203 upregulates SNAI2 and contributes to the invasiveness of malignant breast cancer cells. Genes Cancer 2:782-791.
38. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. 2008. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68:7846-7854.
39. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
40. Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 30:256-268.
41. Aizawa K, Suzuki T, Kada N, Ishihara A, Kawai-Kowase K, Matsumura T, Sasaki K, Munemasa Y, Manabe I, Kurabayashi M, Collins T, Nagai R. 2004. Regulation of platelet-derived growth factor-A chain by Kruppellike factor 5: new pathway of cooperative activation with nuclear factorkappaB. J. Biol. Chem. 279:70-76.
42. Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, Simons JW, Dong JT. 2005. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24:3319-3327.
43. Chen C, Bhalala HV, Qiao H, Dong JT. 2002. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21:6567-6572.
44. Guo P, Dong XY, Zhao KW, Sun X, Li Q, Dong JT. 2009. Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta. J. Biol. Chem. 284:28243-28252.
45. Guo P, Zhao KW, Dong XY, Sun X, Dong JT. 2009. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J. Biol. Chem. 284:18184-18193.
46. Kao YC, Wu LW, Shi CS, Chu CH, Huang CW, Kuo CP, Sheu HM, Shi GY,WuHL. 2010. Downregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelial-mesenchymal transition. Mol. Cell. Biol. 30:4767-4785.
47. Lichti U, Anders J, Yuspa SH. 2008. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3:799-810.
48. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC. 2011. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 13:317-323.
49. Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT. 2010. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc. Natl. Acad. Sci. U. S. A. 107:2485-2490.
50. Chen C, Benjamin MS, Sun X, Otto KB, Guo P, Dong XY, Bao Y, Zhou Z, Cheng X, Simons JW, Dong JT. 2006. KLF5 promotes cell proliferation and tumorigenesis through gene regulation in the TSU-Pr1 human bladder cancer cell line. Int. J. Cancer 118:1346-1355.
51. Parisi S, Cozzuto L, Tarantino C, Passaro F, Ciriello S, Aloia L, Antonini D, De Simone V, Pastore L, Russo T. 2010. Direct targets of Klf5 transcription factor contribute to the maintenance of mouse embryonic stem cell undifferentiated state. BMC Biol. 8:128. doi:10.1186/1741-7007-8-128.
52. Shinoda Y, Ogata N, Higashikawa A, Manabe I, Shindo T, Yamada T, Kugimiya F, Ikeda T, Kawamura N, Kawasaki Y, Tsushima K, Takeda N, Nagai R, Hoshi K, Nakamura K, Chung UI, Kawaguchi H. 2008. Kruppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9. J. Biol. Chem. 283:24682-24689.
53. Gregory PA, Bracken CP, Bert AG, Goodall GJ. 2008. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7:3112-3118.
54. Spaderna S, Brabletz T, Opitz OG. 2009. The miR-200 family: central player for gain and loss of the epithelial phenotype. Gastroenterology 136:1835-1837.
55. Gill JG, Langer EM, Lindsley RC, Cai M, Murphy TL, Kyba M, Murphy KM. 2011. Snail and the microRNA-200 family act in opposition to regulate epithelial-to-mesenchymal transition and germ layer fate restriction in differentiating ESCs. Stem Cells 29:764-776.
56. Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF. 2011. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol. Oncol. 121:200-205.
57. Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M. 2011. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8:633-638.
58. Wang G, Guo X, Hong W, Liu Q, Wei T, Lu C, Gao L, Ye D, Zhou Y, Chen J, Wang J, Wu M, Liu H, Kang J. 2013. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-toepithelial transition and induced pluripotent stem cell generation. Proc. Natl. Acad. Sci. U. S. A. 110:2858-2863.
59. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. 2008. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9:582-589.
60. Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15:740-746.
61. Nieto MA. 2011. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu. Rev. Cell Dev. Biol. 27:347-376.
62. Taylor MA, Parvani JG, Schiemann WP. 2010. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 15:169-190.
63. Moustakas A, Heldin CH. 2007. Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98:1512-1520.
64. Cao L, Feng C, Li L, Zuo Z. 2012. Contribution of microRNA-203 to the isoflurane preconditioning-induced neuroprotection. Brain Res. Bull. 88:525-528.
65. Jin J, Deng J, Wang F, Xia X, Qiu T, Lu W, Li X, Zhang H, Gu X, Liu Y, Cao W, Shao W. 2013. The expression and function of microRNA-203 in lung cancer. Tumour Biol. 34:349-357.
66. Chen Y, Xiao Y, Ge W, Zhou K, Wen J, Yan W, Wang Y, Wang B, Qu C, Wu J, Xu L, Cai W. 2013. miR-200b inhibits TGF-beta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis. 4:e541. doi:10.1038/cddis.2013.22.
67. Hurteau GJ, Carlson JA, Roos E, Brock GJ. 2009. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore Ecadherin expression. Cell Cycle 8:2064-2069.
68. Craig VJ, Cogliatti SB, Rehrauer H, Wundisch T, Muller A. 2011. Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res. 71:3616-3624.
69. Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W, Thilaganathan N, Alvarez CA, Moreira DC, Creighton CJ, Gregory PA, Goodall GJ, Kurie JM. 2011. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 121:1373-1385.
70. Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, Kuninaka S, Shibata T, Ohata H, Nakagama H, Taya Y, Saya H. 2012. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J. Biol. Chem. 287:7896-7906.
71. Primo MN, Bak RO, Schibler B, Mikkelsen JG. 2012. Regulation of pro-inflammatory cytokines TNFalpha and IL24 by microRNA-203 in primary keratinocytes. Cytokine 60:741-748.
72. Ahn SM, Cha JY, Kim J, Kim D, Trang HT, Kim YM, Cho YH, Park D, Hong S. 2012. Smad3 regulates E-cadherin via miRNA-200 pathway. Oncogene 31:3051-3059.
73. Verschueren K, Remacle JE, Collart C, Kraft H, Baker BS, Tylzanowski P, Nelles L, Wuytens G, Su MT, Bodmer R, Smith JC, Huylebroeck D. 1999. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5=-CACCT sequences in candidate target genes. J. Biol. Chem. 274:20489-20498.
74. Mizuguchi Y, Specht S, Lunz JG, III, Isse K, Corbitt N, Takizawa T, Demetris AJ. 2012. Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics. PLoS One 7:e32449. doi:10.1371/journal.pone.0032449.
75. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, Azur Hausen Brunton VG, Morton J, Sansom O, Schuler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T. 2009. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11:1487-1495.
76. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH. 2010. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5:e12445. doi:10.1371/journal.pone.0012445.
77. McKenna DJ, McDade SS, Patel D, McCance DJ. 2010. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J. Virol. 84:10644-10652.
78. Xia H, Cheung WK, Sze J, Lu G, Jiang S, Yao H, Bian XW, Poon WS, Kung HF, Lin MC. 2010. miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J. Biol. Chem. 285:36995-37004.
79. Lim Y, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, Thomas D, Drew PA, Khew-Goodall Y, Goodall GJ. 2013. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stemcell-like state. J. Cell Sci. 126(Pt 10):2256-2266.
80. Nakajima Y, Akaogi K, Suzuki T, Osakabe A, Yamaguchi C, Sunahara N, Ishida J, Kako K, Ogawa S, Fujimura T, Homma Y, Fukamizu A, Murayama A, Kimura K, Inoue S, Yanagisawa J. 2011. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5. Sci. Signal. 4:ra22. doi:10.1126/scisignal.2001551.
81. Nagamatsu G, Kosaka T, Saito S, Honda H, Takubo K, Kinoshita T, Akiyama H, Sudo T, Horimoto K, Oya M, Suda T. 2013. Induction of pluripotent stem cells from primordial germ cells by single reprogramming factors. Stem Cells 31:479-487.
82. Bourillot PY, Savatier P. 2010. Kruppel-like transcription factors and control of pluripotency. BMC Biol. 8:125. doi:10.1186/1741-7007-8-125.
83. Ema M, Mori D, Niwa H, Hasegawa Y, Yamanaka Y, Hitoshi S, Mimura J, Kawabe Y, Hosoya T, Morita M, Shimosato D, Uchida K, Suzuki N, Yanagisawa J, Sogawa K, Rossant J, Yamamoto M, Takahashi S, Fujii-Kuriyama Y. 2008. Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3:555-567.
84. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S, Ng HH. 2008. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10:353-360.
85. Parisi S, Passaro F, Aloia L, Manabe I, Nagai R, Pastore L, Russo T. 2008. Klf5 is involved in self-renewal of mouse embryonic stem cells. J. Cell Sci. 121:2629-2634.
86. Lin SC, Wani MA, Whitsett JA, Wells JM. 2010. Klf5 regulates lineage formation in the pre-implantation mouse embryo. Development 137:3953-3963.
87. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM, Harris CC. 1993. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-839.
88. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE. 1995. p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J. Cell Biol. 128:1185-1196.